Athos Capital’s China Biologic Products Holdings, Inc. CBPO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q2 | – | Sell |
-930,529
| Closed | -$110M | – | 236 |
|
2021
Q1 | $110M | Buy |
930,529
+567,620
| +156% | +$67.2M | 18.4% | 1 |
|
2020
Q4 | $42.9M | Buy |
362,909
+89,877
| +33% | +$10.6M | 11.81% | 2 |
|
2020
Q3 | $30.3M | Buy |
273,032
+3,200
| +1% | +$356K | 14.59% | 1 |
|
2020
Q2 | $27.6M | Buy |
269,832
+256,932
| +1,992% | +$26.3M | 18.83% | 2 |
|
2020
Q1 | $1.39M | Buy |
12,900
+4,610
| +56% | +$497K | 0.97% | 12 |
|
2019
Q4 | $965K | Hold |
8,290
| – | – | 0.96% | 15 |
|
2019
Q3 | $949K | Hold |
8,290
| – | – | 0.93% | 23 |
|
2019
Q2 | $790K | Hold |
8,290
| – | – | 0.35% | 28 |
|
2019
Q1 | $756K | Sell |
8,290
-2,900
| -26% | -$264K | 0.49% | 18 |
|
2018
Q4 | $849K | Buy |
+11,190
| New | +$849K | 0.84% | 15 |
|
2018
Q3 | – | Sell |
-35,266
| Closed | -$3.5M | – | 35 |
|
2018
Q2 | $3.5M | Buy |
+35,266
| New | +$3.5M | 1.19% | 13 |
|